Results 1 to 10 of about 11,939,477 (429)

Mild parenchymal lung disease is still lung disease

European Respiratory Journal, 2020
We read with interest the article by Lewis et al. [1], which reports an increased mortality in patients with idiopathic pulmonary arterial hypertension (IPAH) and mild impairment in computed tomography (CT).
L. Godinas, S. Harari, J. Barberà, D. Montani   +3 more
semanticscholar   +7 more sources

RADIOLOGY IN DISEASES OF THE LUNGS [PDF]

BMJ, 1932
S. Melville
openalex   +4 more sources

Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution

Medical Science Monitor, 2023
The 2023 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report includes relevant topics from the clinician’s perspective and evidence published on chronic obstructive pulmonary disease (COPD) since GOLD 2017. The World Health Organization (
D. Parums
semanticscholar   +1 more source

Calprotectin in Lung Diseases [PDF]

International Journal of Molecular Sciences, 2021
Calprotectin (CLP) is a heterodimer formed by two S-100 calcium-binding cytosolic proteins, S100A8 and S100A9. It is a multifunctional protein expressed mainly by neutrophils and released extracellularly by activated or damaged cells mediating a broad range of physiological and pathological responses.
Ourania S. Kotsiou, Dimitrios Papagiannis, Rodanthi Papadopoulou, Konstantinos I. Gourgoulianis   +3 more
openaire   +4 more sources

Programmatic Implementation of Contact Investigation in Eight African Countries

Tropical Medicine and Infectious Disease, 2022
The objective was to implement CI under national tuberculosis programmatic conditions and to advocate for its scaling up. Contact investigation was implemented in 150 Basic Management Units identified across eight countries.
Kobto G. Koura, Olivia B. Mbitikon, Attannon A. Fiogbé, Abdoul R. Ouédraogo, Albert Kuate Kuate, Aboubacar S. Magassouba, Alphazazi Soumana, Georges Hermana, Barnabé Gning, Mohammed F. Dogo, Monicah Andefa, Gisèle Badoum   +11 more
doaj   +1 more source

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary

European Respiratory Journal, 2023
Executive summary of the Global Strategy for Prevention, Diagnosis and Management of COPD 2023: the latest evidence-based strategy document from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) https://bit.ly ...
A. Agustí, B. Celli, G. Criner, D. Halpin, A. Anzueto, P. Barnes, J. Bourbeau, M. Han, F. Martinez, M. Montes de Oca, Kevin Mortimer, A. Papi, I. Pavord, N. Roche, S. Salvi, D. Sin, Dave Singh, R. Stockley, M. V. Lopez Varela, J. Wedzicha, C. Vogelmeier   +20 more
semanticscholar   +1 more source

Idiopathic pulmonary fibrosis patients with severe physiologic impairment: characteristics and outcomes

Respiratory Research, 2021
Research question There is no widely accepted grading system for IPF disease severity, although physiologic impairment based on pulmonary function testing is frequently employed.
Jean Pastre, Scott Barnett, Inga Ksovreli, Jeannie Taylor, A. Whitney Brown, Oksana A. Shlobin, Kareem Ahmad, Vikramjit Khangoora, Shambhu Aryal, Christopher S. King, Steven D. Nathan   +10 more
doaj   +1 more source

Persistent Post–COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment

Annals of the American Thoracic Society, 2021
Rationale: The natural history of recovery from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains unknown. Because fibrosis with persistent physiological deficit is a previously described feature of patients recovering from similar ...
K. Myall, B. Mukherjee, A. M. Castanheira, J. Lam, G. Benedetti, S. Mak, R. Preston, M. Thillai, A. Dewar, P. Molyneaux, A. West   +10 more
semanticscholar   +1 more source

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.

New England Journal of Medicine, 2021
BACKGROUND No therapies are currently approved for the treatment of pulmonary hypertension in patients with interstitial lung disease. The safety and efficacy of inhaled treprostinil for patients with this condition are unclear.
A. Waxman, R. Restrepo-Jaramillo, T. Thenappan, A. Ravichandran, P. Engel, A. Bajwa, R. Allen, J. Feldman, Rahul G Argula, Peter Smith, K. Rollins, C. Deng, L. Peterson, H. Bell, V. Tapson, S. Nathan   +15 more
semanticscholar   +1 more source

Lung tropism in hospitalized patients following infection with SARS-CoV-2 variants from D614G to Omicron BA.2

Communications Medicine, 2023
Hirotsu, Kakizaki et al. assess the presence of pneumonia and pathogenesis during infection with different SARS-CoV-2 variants. The prevalence of pneumonia differs depending on the infectious variant, with the lowest prevalence and mild lung pathogenesis
Yosuke Hirotsu, Yumiko Kakizaki, Akitoshi Saito, Toshiharu Tsutsui, Syunya Hanawa, Haruna Yamaki, Syuichiro Ide, Makoto Kawaguchi, Hiroaki Kobayashi, Yoshihiro Miyashita, Masao Omata   +10 more
doaj   +1 more source